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Edited by Hans EklundAbstract The phosphate transporter Pho84 of Saccharomyces
cerevisiae is predicted to contain 12 transmembrane (TM) re-
gions, divided into two partially duplicated parts of 6 TM seg-
ments. The three-dimensional (3D) organization of the Pho84
protein has not yet been determined. However, the 3D crystal
structure of the Escherichia coli MFS glycerol-3-phosphate/
phosphate antiporter, GlpT, and lactose transporter, LacY, has
recently been determined. On the basis of extensive prediction
and fold recognition analyses (at the MetaServer), GlpT was
proposed as the best structural template on which the arrange-
ment of TM segments of the Pho84 transporter was ﬁt, using
the comparative structural modeling program MODELLER.
To initiate an evaluation of the appropriateness of the Pho84
model, we have performed two direct tests by targeting spin la-
bels to putative TM segments 8 and 12. Electron paramagnetic
resonance spectroscopy was then applied on puriﬁed and spin la-
beled Pho84. The line shape from labels located at both positions
is consistent with the structural environment predicted by the
template-generated model, thus supporting the model.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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In the yeast Saccharomyces cerevisiae, the Pho84 protein is
the primary inorganic phosphate transporter at conditions
when the external availability of this nutrient is limited (for a
recent review, see [1]). At such conditions, the PHO regulon
(reviewed in [1,2]) upregulates the expression of the PHO84
gene [3] and the synthesized protein is routed to the plasma
membrane [4] where it is active in proton coupled phosphate
transport [5]. The Pho84, belonging to the family of phos-
phate:proton symporters (TC No. 2.A.1.9; [6]), is a member
of the major facilitator superfamily (MFS; [7,8]). The Pho84
(587 amino acid residues) is predicted to consist of 12 trans-
membrane (TM) segments, which can be seen as two homolo-Abbreviations: EPR, electron paramagnetic resonance; MFS, major
facilitator superfamily; MTS, (1-oxyl-2,2,5,5-tetramethylpyrroline-3-
methyl) methanethiosulfonate; SDSL, site-directed spin label; TM,
transmembrane
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doi:10.1016/j.febslet.2004.11.012gous sequence segments each containing 6 TM regions that are
separated by a predicted large central loop. This organization,
likely reﬂecting ancestral gene duplication, appears to be
common among the MFS proteins [9–11]. Recently, the
three-dimensional (3D) structure of two other MFS proteins,
the lactose permease (LacY) and the glycerol-3-phosphate/
phosphate antiporter (GlpT) of Escherichia coli, was deter-
mined to an atomic resolution of 3.5 A˚ [12] and 3.3 A˚ [13],
respectively. These studies revealed that the postulated dupli-
cation seen in MFS proteins is indeed present in the 3D struc-
ture of the folded proteins.
In this communication, we focus on the structural aspects of
the Pho84 protein. Our two-step aﬃnity puriﬁcation system of
dual-tagged Pho84 expressed in E. coli is described together
with the applied electron paramagnetic resonance (EPR) spec-
troscopy analysis. The ﬁrst 3D structure model of the Pho84
protein, based on the published GlpT structure, is presented
and discussed.2. Materials and methods
2.1. Materials
Thio-speciﬁc nitroxide spin label (MTS-SL; (1-Oxyl-2,2,5,5-tetra-
methylpyrroline-3-methyl) methanethiosulfonate) was purchased from
Reanal Finechemical (Budapest, Hungary). Horseradish peroxidase-
conjugated anti-mouse-Ig-antibody (from sheep) and enhanced chemi-
luminescence detection kit were obtained from Amersham Bioscience,
UK. Anti-Xpress antibody, plasmid pTrcHisB and E. coli TOP10F0
cells were obtained from Invitrogen, The Netherlands. Anti-FLAG
antibody, anti-FLAG resin and FLAG peptide were purchased from
Sigma. Expand High Fidelity polymerase was from Roche. Oligonu-
cleotide primers were purchased from TAG Copenhagen A/S, Den-
mark. Cybergene AB, Sweden, performed DNA sequence analyses.
2.2. Plasmid constructions
The PHO84 gene was PCR ampliﬁed from genomic yeast DNA
using sense (5 0-GAGAGAGGATCCGATGAGTTCCGTCAATAA-
AGAT) and antisense (5 0-GAGAGAGAATTCTTATTTATCG-
TCATCGTCTTTATAATCTGCTTCATGTTGAAGTTG) primers,
which harbored the BamHI and EcoRI endonuclease sequences,
respectively. A stretch of DNA corresponding to the FLAG antibody
epitope (DYKDDDDK) was also present, prior to the stop codon, in
the antisense primer. PCR products were restriction digested with
BamHI and EcoRI and subsequently ligated in frame into a pTrcHisB
plasmid that had been treated with the same enzymes. The resulting
plasmid, pTrcHisB-His6/Xpress-PHO84-FLAG, was transformed into
TOP10F 0 E. coli cells, plated on solid LB-ampicillin medium and
incubated o/n at 37 C. DNA sequence analysis was performed to ver-
ify the integrity of open reading frames of the positive colonies. The
two single cysteine mutant constructs (S402C and L530C) were made
in two consecutive PCRs, where the products of the ﬁrst reactions
were used as primers in the second ampliﬁcation reactions. For this,ation of European Biochemical Societies.
J.O. Lagerstedt et al. / FEBS Letters 578 (2004) 262–268 263oligonucleotide primers for the S402C (5 0-TCTGCTGGTTGTTTA-
CCTGGT) and for the L530C (5 0-ATTTTCGCCTGTTTCATGTTG)
mutations were used, together with the above-mentioned BamHI and
EcoRI primers. The previously described cysteine free PHO84 [14]
was used as template. The PCR products were ligated into plasmid
pTrcHisB, transformed into TOP10F 0 cells and DNA sequence con-
ﬁrmed as described above.
2.3. Expression in E. coli
Cells harboring the diﬀerent plasmid constructs were cultivated o/n
in 150 ml LB medium supplemented with 50 lg/ml ampicillin. The full
volume was transferred to a broad-based 2.8 liter Erlenmeyer ﬂask and
mixed with 1.5 liter Terriﬁc Broth (50 lg/ml ampicillin) medium giving
a spectral absorbance of about 0.1 at 600 nm (A600). The culture was
grown aerobically at 200 rpm and 30 C. At an A600 of 0.6, 1 mM iso-
propyl 1-thio-b,D-galactopyranoside (IPTG) was added. After 6 h of
induction, cells were harvested by centrifugation at 8000 · g for 10
min. Cell pellets were stored at 80 C.
2.4. Extraction of protein
Cells thawed on ice were resuspended in 40 ml sterile-ﬁltered buﬀer
A (50 mM Tris–HCl (pH 7.6), 0.2 M NaCl, 10 mM MgCl2, 30 mM
imidazole, 10% glycerol, and 0.1% Triton X-100; 0.45 lm ﬁltered) to
which lysozyme and 1 mM phenylmethylsulfonyl ﬂuoride (PMSF)
were added. Alternatively, where indicated, 50 mM sodium-phosphate
replaced the Tris in buﬀer A. The suspension was incubated for 40 min
at 4 C. 10 ml portions of the chilled viscous suspension were sonicated
for 20 s with a micro-tip sonicator. Triton X-100 and dodecylmaltoside
were added to a ﬁnal concentration of 0.4% and 0.1%, respectively, and
the suspension was incubated for an additional 30 min at 4 C followed
by a repetition of the sonication step. Cell debris and unbroken cells
were separated from solubilized protein by high-speed centrifugation
for 30 min at 100000 · g. The ﬁltrated (0.22 lm) supernatant was
immediately used for dual-aﬃnity puriﬁcation.
2.5. Aﬃnity puriﬁcation
The protein extract (40 ml) was applied at a ﬂow rate of 1 ml/min
onto a 1 ml Hi-Trap column (Amersham Bioscience), connected on-
line to a FPLC system and pre-charged with Ni2+ according to the
manufacturers protocol. Buﬀer A with an imidazole concentration
of 50 mM was used to prevent binding of protein contaminants hav-
ing a low aﬃnity for the resin. The enriched Pho84 protein was
eluted with 300 mM imidazole in buﬀer A. The eluate (4 ml) was di-
rectly incubated with 200 lM MTS spin label at 4 C for 30 min to
generate spin-labeled protein (detergent-solubilized) and then applied
onto the 1 ml anti-FLAG resin (Sigma) column, activated according
to the manufacturers protocol. After a second passage of the protein
mixture, contaminants were washed out with 40 ml buﬀer A modiﬁed
to contain no glycerol, imidazole or MgCl2. This allowed excess label
to be eﬃciently removed. Finally, a gentle elution of the Pho84 was
performed using 400 lg FLAG peptide (Sigma) dissolved in 4 ml
glycerol, imidazole and magnesium free buﬀer A. The 4 ml fraction
was concentrated to 1 ml using a 4 ml capacity Ultrafree Centrifru-
gal Filter with a 50 kD cutoﬀ BIOMAX membrane (Millipore, Bed-
ford, MA, USA). The sample was further concentrated to 200 ll
using a 0.5 ml capacity microspin concentrator (BIOMAX mem-
brane) with a 10 kD cutoﬀ.
2.6. EPR spectroscopy
EPR measurements were carried out in a JEOL X-band spectrome-
ter ﬁtted with a loop-gap resonator [15,16]. An aliquot (5 ll) of puri-
ﬁed, spin-labeled protein was placed in a sealed quartz capillary
contained in the resonator. Spectra of samples at room temperature
(20–22 C) were from a single 60-s scan over a ﬁeld of 100 G at a
microwave power of 2 mW and a modulation amplitude optimized
to the natural line width of the individual spectrum (0.5–1.5 G).2.7. Protein analysis
Samples of puriﬁed protein were mixed with sample buﬀer prior to
separation by SDS–polyacrylamide gel electrophoresis using a 10%
Laemmli system [17]. Immunoblotting was carried out on poly(vinyli-
dene diﬂuoride) membranes (Immobilon-P, Millipore) according to the
Western Blotting Protocol (Amersham Bioscience). Use of anti-Xpress(Invitrogen, The Netherlands) and anti-FLAG (Sigma) monoclonal
mouse antibodies, and horseradish peroxidase-conjugated anti-
mouse-Ig-antibody (Amersham Bioscience) allowed for immunological
detection of the Pho84 proteins. After a short incubation with chemi-
luminescent substrates, the blot was exposed to ﬁlm for 1 min.
Protein was assayed by use of the commercially available Bio-Rad
Dc Protein Assay kit (Bio-Rad) and bovine serum albumin was used
as a standard.
2.8. Structural modeling of Pho84
Potential secondary and 3D structure models of the Pho84 protein
were analyzed from its primary sequence by use of several local struc-
ture and fold recognition methods at the MetaServer (bioinfo.pl/meta/)
[18] (i.e., PDB-Blast, 3D-Jigsaw, EsyPred3D, GRDB, FFAS03, Sam-
T99, Superfamily, INBGU, FUGUE2, 3D-PSSM, mGenTH-
READER, psipred, and profsec). These were jointly evaluated by
the Pcons and 3D-Jury methods (at the same server). The established
structure of the protein with the highest scores (GlpT; PDB code
1PW4) was used as template in the structural modeling of the Pho84
protein using the comparative modeling program MODELLER [19],
in which the calculated 3D model was obtained by optimally satisfying
spatial restraints derived from the 3D-Jury sequence alignment. The
alignment of the Pho84 amino acid sequence with the GlpT sequence
is from the evaluation of all the individual methods (cf. above) by
the 3D-Jury system, where some loop regions had no ﬁt. Analysis of
the Pho84 structural model was performed by use of the DeepView/
Swiss-PdbViewer program (www.expasy.org/spdbv) and also by use
of Insight II software (version 2000.1) on the Octane workstation by
Silicon Graphics. The ﬁgures shown were produced by use of the latter.3. Results and discussion
3.1. Pho84 structure model
From the Pho84 primary structure, a number of prediction
and fold recognition methods (cf. Section 2) at the MetaServer
(bioinfo.pl/meta/) [18] proposed substantial structural similar-
ities to several MFS protein structures. Highly signiﬁcant
scores were given from the joint comparison of the individual
methods by the 3D-Jury and Pcons evaluation systems (bio-
info.pl/meta/) for similarity to the E. coli glycerol-3-phos-
phate/phosphate antiporter (GlpT; PDB code 1pw4) and
lactose permease (LacY; PDB code 1pv6) structures, and two
theoretical structure models in the PDB database (human glu-
cose transporter GLUT1 (PDB 1ja5a) and the Plasmodium
hexose transporter PfhT1 (PDB 1lvia)). Both of the former
two MFS proteins contain 12 TM domains and with extended
central loops connecting the two homologous parts, and have
superimposable TM parts of their structures [20]. Interestingly,
both structures exhibited a pseudo twofold symmetry also on
the 3D level [12,13]. The GlpT structure was used as a template
for comparative modeling of the Pho84; its Pcons2 score (4.43)
was similarly high as for a previous successful and validated
structure model of a membrane surface protein [21]. The align-
ment between the two sequences was determined by the joint
outcome from the individual methods, as shown by the
3D-Jury system, and illustrated in Fig. 1. The resulting 3D
structure model with 12 TM regions is shown in Fig. 2(a). Gen-
erally, prokaryotic MFS proteins are smaller, with shorter
loops and terminal extensions than eukaryotic members of
the superfamily (discussed in [8]). Similarly, the GlpT is smal-
ler than the Pho84 (452 vs. 587 amino acids). Based on the pri-
mary structure alignment (Fig. 1), it is obvious that the
majority of the additional amino acids in the Pho84 structure
constitute the comparatively long N- and C-terminal exten-
sions (amino acids 1–37 and 557–587, respectively). These
Fig. 1. Alignment of Pho84 with MFS transporters. Pho84 was predicted similar to several MFS transporter structures by a number of well-
established secondary structure and fold recognition methods at the MetaServer [18]. The alignment of the sequences is from the joint evaluation of
the outcome by the 3D-Jury system. The predicted TM helices of Pho84 are visualized in dark gray, and the established helices of the PDB structures
are in light gray (note the lack of ﬁt for some loop regions). The proteins most similar to Pho84 were (in rank) the bacterial glycerol-3-phosphate/
phosphate antiporter (GlpT; PDB code 1pw4) and lactose permease (LacY; PDB code 1pv6), the human glucose transporter (GLUT1; PDB code
1ja5a) and the Plasmodium hexose transporter (PfhT1; PDB code 1lvia). Boxes depict the conserved MFS signature motifs discussed in Section 3.
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GlpT structural template. Consequently, in Fig. 2(a) the struc-
tural model is represented by amino acids S52 to K546 ofPho84. However, it should be noted that TM segment predic-
tions based on hydrophobicity and charge distribution do not
always yield the correct number of segments, i.e., the superior
Fig. 2. Structural model of Pho84. (a) Front-view (left) of the Pho84 structure (amino acids S52 to K546) in the plane of the lipid bilayer is shown
and also a top-view presentation (right) where the numbering of the individual helices is shown (inset). N and C refer to the N- and C-termini,
respectively, of the Pho84. (b) A 2D presentation of the Pho84 based on the 3D structure model. Transmembrane segments are indicated as blue
boxes. The secondary structure within the TM domains as predicted by MODELLER using the GlpT template is also highlighted. Most of the
residues within the TM domains are on an a helical backbone (blue circles), whereas series of amino acids predicted to have random coil character are
highlighted by yellow circles.
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ments for Pho84 (data not shown).
Several conserved motifs are found in MFS proteins (boxes
in Fig. 1). The pentameric amino acid sequence RxGRR (x is
any amino acid and R may be replaced by K) is one such motifcommonly found in the loops connecting TM 2 and 3 and also
TM 8 and 9 (discussed in [8]). In the human Glut1 glucose
transporter, such positive charges found at the corresponding
loops have been shown to be important for correct insertion
and topological orientation of the immediate TM segments
Fig. 3. Dual-aﬃnity puriﬁcation of Pho84. Protein eluted from the
Ni2+ (a) and FLAG (b) aﬃnity columns were solubilized and separated
by SDS–PAGE. The protein purity was analyzed and compared by
Coomassie staining (C) and the identity of the Pho84 fusion protein
(arrow) was determined by Western blot (W) analysis using both anti-
FLAG (shown here) and anti-Xpress (not shown) monoclonal
266 J.O. Lagerstedt et al. / FEBS Letters 578 (2004) 262–268[22]. The corresponding loops of the GlpT structure contain
partly conserved sequences (RsnpR and RnGRf, respectively;
[13]) and they are also present in the Pho84 protein (ivGRK
between TM 2 and 3 and iiGRK between TM 8 and 9, respec-
tively; Fig. 2(b); [1]), possibly indicating a similar function as
an important determinant of the Pho84 protein topology.
Another highly conserved motif that can be found in both
halves of the Pho84 protein (PESPR and PETKR in the N-
and C-terminal half, respectively) is the PEST-rich sequence.
This sequence has been ascribed a role in degradation both
in MFS [23] and in ATP-binding cassette [24] proteins. Previ-
ously, we have observed that the Pho84 protein undergoes reg-
ulated cleavage approximately in the middle of the primary
structure of Pho84 [25]. The N-terminal PEST-rich sequence
of Pho84 (i.e., PESPR) is localized to positions 271–275. This
is at the end of TM 6 in the structure and these amino acids
protrude from the membrane domain on the cytosolic side
and thus are accessible for modiﬁcations by cellular factors.
antibodies.3.2. Production of puriﬁed Pho84
Initially, we wished to make use of a previously described
bacterial expression system [26] to obtain suﬃcient amounts
of highly puriﬁed and solubilized Pho84 for EPR spectroscopic
analysis. This setup is based on a single chromatographic puri-
ﬁcation step where the catalytically active Pho84 protein, fused
with an N-terminal consecutive hexa-histidine sequence and an
Xpress antibody epitope, is retained on a Ni2+ column and
eluted with an increased concentration of imidazole. In that
study, the catalytically active fusion protein was incorporated
in liposomes, which, in fact, constituted a second puriﬁcation
step of the transporter. For the present study, however, puri-
ﬁed Pho84 protein in a soluble state was preferred. In order
to eﬃciently eliminate contaminating proteins in the 50–300
mM imidazole elution, and thus increase the purity and yield
of puriﬁed Pho84, a dual aﬃnity expression and puriﬁcation
was elaborated. For this, the PHO84 gene was inserted in
the pTrcHisB expression plasmid together with a ﬂanking se-
quence encoding the FLAG antibody epitope (DYKDDDDK)
at the C-terminal end of Pho84 (Fig. 3). After IPTG induced
expression in TOP10F 0 E. coli cells and solubilization of pro-
teins, the total cell protein extract was applied onto the Ni2+
charged HiTrap column in the presence of imidazole at a con-
centration of 30 mM (in Tris or sodium-phosphate buﬀer).
After washing with buﬀer containing 50 mM imidazole, the
Pho84 fusion protein was eluted with 300 mM imidazole.
The eluted fraction (about 4 ml) contained essentially all
Pho84 protein that had initially been retained on the column.
In order to remove the remaining contamination proteins, the
eluted volume was immediately allowed to pass the anti-FLAG
antibody resin twice followed by extensive washing. Finally,
competitive binding of pure FLAG peptide to the resin specif-
ically eluted the Pho84 fusion protein (Fig. 3). The eluted vol-
ume (4ml) typically containing 1–2 mg of protein (from the 1.7
liter culture) was immediately used for further analysis. The
purity and yield were independent on whether Tris or phos-
phate (not shown) was used as buﬀering system. A single
FLAG aﬃnity puriﬁcation step (not shown) yielded protein
at a lower purity; hence, both chromatographic steps were
judged to be necessary. The functional consequence of the
FLAG epitope addition to the C-terminal end of Pho84 has
been examined in vivo. In that analysis, a pRS416 based plas-mid construct harboring the PHO84-FLAG under control of
its natural promoter showed that the Pho84-FLAG has a re-
tained capability to transport phosphate in Dpho84 yeast cells
under phosphate limiting conditions (Lagerstedt, Pattison-
Granberg and Persson; unpublished results). Similarly, the
functionality of the Pho84 protein with the hexa-histidine
and Xpress epitope sequences fused to the N-terminus has
been demonstrated in a reconstituted system [26].
Several advantages of this dual-aﬃnity system can be identi-
ﬁed: (i) using the aﬃnity of the hexa-histidine for chelated Ni2+
ions as a ﬁrst, bulk puriﬁcation method allows for the collec-
tion of essentially all extracted Pho84 protein, partly puriﬁed
and in a reduced volume, (ii) as judged by Western blot anal-
ysis, the FLAG antibodies have very low cross-reactivity with
endogenous E. coli proteins, (iii) the use of two speciﬁc aﬃni-
ties eﬀectively diminishes the presence of contaminants in the
ﬁnal protein preparation, (iv) elution with peptide can be per-
formed at physiological pH, and (v) the use of aﬃnity tags at
the extreme N- and C-terminal ends ensures that only protein
with an intact primary structure is puriﬁed.
3.3. EPR spectroscopic analysis
Site-directed spin label (SDSL) EPR spectroscopy analysis
has proven to be a very powerful technology to study struc-
tural aspects of all kinds of proteins [27,28] and other biolog-
ical molecules such as lipids [29,30], DNA [31] and RNA [32]
and also in protein–protein [33] and protein–lipid [34] interac-
tion studies. In particular, SDSL-EPR has been widely used
for the elucidation of structural aspects of membrane-spanning
proteins, which due to their hydrophobic properties are diﬃ-
cult to analyze with conventional crystallographic technolo-
gies, (reviewed in [35]). In these studies, the biological
molecule is modiﬁed at a chosen location with a sulfhydryl-
speciﬁc nitroxide reagent to introduce a paramagnetic side-
chain. Cysteine residues are commonly utilized for this thiol
binding of the nitroxide, an approach that most often is pre-
ceded by site-directed mutagenesis.
The primary structure of the Pho84 protein harbors 12 na-
tive cysteines. These are located both in the hydrophobic
TM regions and in the more hydrophilic loops (Fig. 2(b)). A
cysteine free PHO84 construct where all native cysteines were
replaced with serines was previously constructed and shown to
Fig. 4. EPR analysis (a) of S402C and L530C in the presence (red) or
absence (black) of 2 mM Mg2+ together with locations (b) in Silicon
Graphics produced structures of local domains.
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identical to the unmodiﬁed Pho84 [14]. Based on this cysteine
free PHO84 template, single cysteine mutants were created in
TM segment 8 (TM8; S402C) and TM segment 12 (TM8;
L530C). These two locations were chosen to exemplify two
TM regions assumingly being part of the inner core (TM8)
and outer fence (TM12) of the Pho84 structure.
The detergent-solubilized mutants were MTS spin labeled
in the puriﬁcation process as described in Section 2 and
EPR analysis was performed. As can be seen in Fig. 4,
the spectra derived from both positions reﬂect a tightly
packed environment. The shapes of these spectra, acquired
from spin labeled Pho84 in phosphate buﬀer, were also ob-
tained from labeled Pho84 in Tris buﬀer (not shown). Since
Mg2+ is known to aﬀect the functional properties of Pho84
by a drastic reduction of the phosphate uptake capacity [36],
we also examined whether the spin labels located on TM 8
or 12 are conformationally sensitive to Mg2+. Thus, also
shown in Fig. 4 are the EPR spectra of spin labeled
S402C and L530C in the presence of 2 mM MgCl2. Since
the +/ Mg2+ samples contain identical amounts of protein,
the spectrum of the S402C protein is clearly more broadened
in the presence of Mg2+, while no signiﬁcant change is re-
ported from the label located on TM 12. Since similar, albeit
less pronounced, response is seen for spin labeled S402C in
Tris buﬀer (not shown), the Mg2+ eﬀect appears to be phos-
phate independent. The broadening at position 402 could
arise from a further restriction of motion, such as a loss
in backbone or side chain dynamics [37]. However, the lack
of increased amplitude in the hyperﬁne extrema or change in
the central linewidth suggests an increase in a magnetic
dipolar interaction between labels in close proximity, which
may be responsible for the Mg2+-induced broadening. Thus,
Mg2+ may inﬂuence the oligomeric state of Pho84 or the rel-
ative arrangement of associated proteins in a complex. Posi-
tions within TM8 may therefore be useful for probing
conformational dynamics associated with function. In the
structurally related protein LacY (cf. above), the corre-sponding TM 8 seems to be part of a region that is labile
to structural changes, i.e., the ‘‘rotation’’ between the ﬁrst
and second halves (two domains) of the protein during
membrane insertion in a lipid-modiﬁed mutant [38].
Our structural model places both positions 402 and 530 in a
tightly packed interior environment. Such buried positions in
proteins display a characteristic EPR spectrum with broad
splittings when labeled with the MTS spin label employed in
these studies [27]. Since the nitroxides at both 402 and 530 re-
port such an environment, we have demonstrated how the
model can be directly tested for accuracy. Further probing sites
predicted to fall on lipid-exposed faces of the TM domains or
in the loop regions with spin labels will conﬁrm whether the
sites reﬂect a more ﬂexible location as predicted.
The combination of our dual-aﬃnity puriﬁcation system
with SDLS EPR spectroscopy, possibly in combination with
NMR as described elsewhere [39], will allow us to improve
the present model by adding on experimentally determined re-
straints such as deﬁned distances between residues in the
Pho84 structure.
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